Ustozlar uchun
pedagoglar.org
73-son 3–to’plam Iyun-2025
Sahifa: 64
GAMMA-AMINOBUTYRIC ACID (GABA): PHYSICOCHEMICAL
PROPERTIES AND ITS SIGNIFICANCE IN MEDICINE.
Khaydarova H.A.
Bukhara State Medical Institute
named after Abu Ali ibn Sino
Keywords.
Gamma-Aminobutyric Acid (GABA), GABA, physicochemical
properties, medical significance, neurotransmitter, brain function, neurological disorders,
health benefits, biochemical properties, medical applications.
Annotation.
Gamma-aminobutyric acid (GABA) is one of the most important
naturally occurring amino acids in the human div. It functions primarily as the chief
inhibitory neurotransmitter within the central nervous system (CNS). Discovered in the
mid-20th century, GABA’s primary role is to reduce neuronal excitability, thus
maintaining the balance between excitation and inhibition essential for normal brain
function. Beyond its neurological function, GABA exhibits numerous physiological
effects, and its derivatives and analogs are increasingly used in medicine. This essay
provides a detailed analysis of the physicochemical properties of GABA, its biological
significance, and its applications in the medical and pharmaceutical fields.
Chemical Structure and Physicochemical Properties. Chemical Structure. GABA's
chemical formula is C4H9NO2. It is a non-essential amino acid with the following
structural features: An amino group (-NH2)A carboxyl group (-COOH)A four-carbon
chain linking these groups, with the amino group attached to the gamma position (the third
carbon from the carboxyl group) This gamma position distinguishes GABA from classical
amino acids such as alanine or glycine, which have amino groups at the alpha position.
Physical PropertiesMolecular weight:
approximately
103.12 g/mol
Melting point:
about 200°C under standard conditions
Solubility:
Water-soluble owing to its polar amino and carboxyl groups; poorly
soluble in non-polar solvents
Appearance:
White crystalline powder
Stability:
GABA is relatively stable under physiological conditions but can degrade
upon exposure to heat and strong acids or bases
GABA has reactive functional groups that enable it to participate in various
biochemical reactions:
Acid-base interactions: It can act as both an acid and a base
Ustozlar uchun
pedagoglar.org
73-son 3–to’plam Iyun-2025
Sahifa: 65
Participation in biosynthesis and catabolism: It is synthesized from glutamate via the
enzyme glutamate decarboxylase (GAD), and broken down via GABA transaminase
(GABA-T)
GABA is synthesized in the brain by the decarboxylation of glutamate, catalyzed by
GAD:
Glutamate→GADGABA+CO2GlutamateGADGABA+CO2
It is primarily metabolized in neurons and glial cells via the GABA shunt pathway
involving GABA transaminase and succinic semialdehyde dehydrogenase, ultimately
connecting GABA metabolism with the Krebs cycle. This tight regulation underscores
GABA’s role in maintaining neuronal excitability.
GABA accounts for about 30-40% of inhibitory synapses in the mammalian brain,
effectively reducing neuronal firing rates. By binding to GABA receptors (mainly
GABA_A and GABA_B receptors), it:
Opens chloride channels (GABA_A), leading to hyperpolarization and inhibitory
postsynaptic potentials
Activates G-protein-coupled receptors (GABA_B), modulating ion channels and
intracellular signaling
This inhibitory action stabilizes overall neural activity, preventing overstimulation,
seizures, or neurotoxicity.
In Mood and Anxiety Regulation: GABA deficit is linked with anxiety disorders, and
GABA-enhancing drugs have anxiolytic effects.
In Sleep Regulation: GABA facilitates sleep induction; many hypnotic drugs target
GABA receptors.
In Muscle Relaxation: GABA’s inhibitory effect on motor neurons helps in muscle
tone regulation.
In Neurodevelopment: GABA influences neuronal growth, differentiation, and
synaptogenesis during brain development.
Due to its inhibitory functions, exogenous GABA or its analogs are used to treat
various neurological and psychiatric conditions:
Epilepsy: GABA agonists like benzodiazepines enhance GABAergic activity to
prevent seizures.
Anxiety and Stress Disorders: GABAergic drugs, such as valproic acid, are used as
anxiolytics.
Sleep Disorders: GABA-enhancing agents promote sleep by potentiating inhibitory
signaling.
Parkinson’s Disease: GABA agonists may help reduce tremors and motor symptoms.
Since GABA does not cross the blood-brain barrier efficiently, its direct oral
supplementation has limited central activity. However, GABA analogs such as phenibut,
Ustozlar uchun
pedagoglar.org
73-son 3–to’plam Iyun-2025
Sahifa: 66
baclofen, and gabapentin have been developed to mimic its effects centrally or
peripherally:
Baclofen:
Used as a muscle relaxant
Gabapentin:
Used for neuropathic pain and epilepsy
Phenibut:
Used as an anxiolytic in some countries
Recent research explores GABA’s role in neurodegenerative diseases, depression,
and cognitive enhancement. For example:
Nootropic effects: Some studies suggest GABA analogs can improve cognitive
function.
Immunomodulation: GABA receptors are found on immune cells, indicating potential
in immunotherapy.
Oncology: New insights into GABAergic signaling imply possible roles in cancer
growth regulation.
Despite its well-established role, the therapeutic use of GABA and its derivatives
faces challenges:
Blood-brain barrier permeability: Limiting direct GABA use; hence, focus on analogs
or modulators of GABA receptors.
Side effects: Sedation, dizziness, and dependency potential with some agents.
Research gaps: The precise molecular mechanisms and long-term effects of
GABAergic drugs need further exploration.
Conclusion
Gamma-aminobutyric acid (GABA) is a fundamental amino acid with crucial roles in
the nervous system. Its physicochemical properties—solubility, stability, and reactivity—
enable its function as a primary inhibitory neurotransmitter. The profound influence of
GABA on neuronal activity underpins its therapeutic applications in various neurological
and psychiatric diseases. Ongoing research aims to discover new derivatives, improve drug
delivery systems, and extend its clinical benefits. As science advances, GABA remains a
promising target for developing innovative treatments for numerous central nervous
system disorders.
References:
1.
Bloom, F. E. (1990).
The GABA system in the brain
. Annual Review of Pharmacology and
Toxicology, 30(1), 283–310.
2.
Oliveira, S. et al. (2018).
GABA in the central nervous system: Its role and therapeutic
potential.
Neurochemical Research, 43, 465–477.
3.
Mody, I., & Pearce, J. M. (2004).
Good-drug/bad-drug: GABA_A receptor modulators.
Trends in
Pharmacological Sciences, 25(3), 143–147.
4.
Brambilla, P., & Sassi, S. (2018).
GABAergic modulation: new avenues for the treatment of
neurological disorders.
Current Drug Targets, 19(5), 543–556.
5.
Liu, R. J., & Nuss, P. (2010).
GABA as a modulator of neuroplasticity.
Current Neuropharmacology,
8(4), 387–399.
6.
Boni, R., et al. (2017).
Pharmacological approaches targeting GABA system in neurodegenerative
disorders.
Frontiers in Pharmacology, 8, 68.
